Search

everythinglearnresearchcommunity

for

Search:↓

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

Canakinumab's effect on COVID-19 outcomes is unclear.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

A new mutation in the CYP11B1 gene was found in a woman with mild hyperandrogenemia, a rare cause of non-classic congenital adrenal hyperplasia.

Scientists made two new chemicals that might help treat diseases caused by male hormones.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

The P133R mutation in AKR1D1 enzyme causes harmful bile acid buildup, explaining related health issues.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Midazolam's seizure prevention is partly due to increased neurosteroid production.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Chlormadinone acetate is useful for birth control and treating various hormonal issues.

Activating Tgr5 may help treat hair loss and bone loss.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Cedrol may help treat inflammatory bowel disease by improving gut health and function.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

CD271 is crucial for maintaining healthy skin and preventing inflammation.

Baricitinib is effective as a treatment for severe hair loss.

Pranlukast and mirabegron may work as new diabetes drugs.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.

MEK and BRAF inhibitors increase sebum production and accumulation, which could cause acne-like side effects.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

Baricitinib helps regrow scalp, eyebrow, and eyelash hair in teens with severe alopecia areata.

GLP-1 agonists may increase the risk of hair loss.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.